Accordingly, the Morari group reported that LRRK2 PF and MLi2 inhibitors protected from 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)-induced neurotoxicity and gliosis [28]. This evidence concerns the gene LRRK2 and Gliosis.